# US Artificial Kidney Market

> United States Artificial Kidney Market Research Report: Size, Share, Trend Analysis - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 60.22%
- **2024:** $ 115.4 Million
- **2025:** $ 184.9 Million
- **2035:** $ 20,616.12 Million
- **Key Players:** Fresenius Medical Care (DE), DaVita Inc. (US), Baxter International Inc. (US), Nipro Corporation (JP), Medtronic plc (IE), Asahi Kasei Corporation (JP), KfH Kidney Center (DE), Dialysis Clinic, Inc. (US)

**Report ID:** MRFR/HC/14146-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-artificial-kidney-market-15673

---

## Market Summary

## US Artificial Kidney Market Highlighted Trends & Dynamics

The market for artificial kidneys in the US is very busy right now. It's because more and more people have kidney failure and need more advanced ways to replace their kidneys. Bioartificial or internal kidneys, which are also called artificial kidneys, might be a good long-term option to dialysis and kidney transplants.

Donors of kidneys dropped by a lot around the world during the COVID-19 outbreak. The market for artificial kidneys changed a lot because of this. A study in Transplantation in June 2022 found that during COVID-19, there was a 16% drop in donations all over the world. The treatments for kidneys were the ones that changed the most. Less surgery on the kidneys could be good for the market for robotic kidneys to grow. Medicines and organ replacements took longer to get to people who needed them in the early stages of the pandemic.

More and more people in the US are getting kidney illnesses like ESRD and CKD over time. This is a big reason why we need new ways to replace kidneys. Because kidney diseases happen so often, scientists need to come up with new ways to help people who have them do better.

Giving a kidney or going on regular dialysis can save lives, but it's hard to get to these places and needs strong drugs that make the immune system weak for life. As more people look for better, more eco-friendly options, artificial kidneys are becoming more popular.

The US market for artificial kidneys is growing quickly, which is good for bioengineering and regenerative medicine. We can now make artificial kidneys that look and work like real ones because biomaterials, tissue engineering, and 3D printing are all getting better. This could change the way kidney care is given in a big way.

People all over the country are getting artificial kidneys to wear more and more. With this kind of handy medical gear, people can get dialysis at home while going about their daily lives. With this tool, someone with end-stage kidney disease can stay out of the hospital longer and have lower blood pressure. This makes their life better. The body doesn't hold on to salt, and the risk of stroke and heart disease goes down. Also, it costs less than other medicines for adults with kidney failure.

The trend toward personalized care is changing how an artificial kidney is made so that it fits the needs of each patient. This method tries to take into account that every patient's body is different so that the treatment works better and there are fewer side effects.

Though man-made kidneys may be less expensive than dialysis and replacements that need to be done over and over, they are still in their early stages. Because of the high costs of medical bills and lost work time that come with chronic kidney diseases, it is even more important to find long-term answers.

Science is hard, rules and laws are hard to understand, and there needs to be a lot of clinical tests in the US Artificial Kidney market. But the market should keep growing as long as science and technology keep getting better. The way kidney donation treatments are done might change because of this. This could improve the lives of people with kidney illnesses. It looks like robotic kidneys could be a big part of changing how kidney patients in the US are cared for in the future.

## Market Drivers

### Rising Awareness and Education

There is a growing awareness regarding kidney health and the importance of early detection of kidney diseases among the US population. Educational campaigns by healthcare organizations and non-profits are playing a crucial role in informing the public about the risks associated with kidney diseases and the available treatment options, including artificial kidneys. This heightened awareness is likely to lead to increased screening and diagnosis, subsequently driving demand for artificial kidney solutions. The artificial kidney market stands to benefit from this trend as more patients seek advanced treatment options upon diagnosis. Furthermore, as healthcare providers emphasize patient education, the market may witness a shift towards proactive management of kidney health, thereby enhancing the overall demand for artificial kidney technologies.

### Government Initiatives and Funding

Government initiatives aimed at improving kidney health and funding for research are pivotal in shaping the artificial kidney market. The US government has allocated substantial resources to kidney disease research, with programs designed to enhance treatment options and patient outcomes. For instance, the Kidney Health Initiative, a public-private partnership, focuses on accelerating the development of new therapies, including artificial kidneys. Such initiatives not only foster innovation but also create a favorable regulatory environment for the artificial kidney market. Increased funding for clinical trials and research projects is likely to lead to breakthroughs in artificial kidney technologies, further stimulating market growth. As these initiatives gain traction, they are expected to attract investments and encourage collaboration among stakeholders.

### Technological Innovations in Dialysis

Recent advancements in dialysis technology are significantly influencing the artificial kidney market. Innovations such as wearable artificial kidneys and bioengineered devices are emerging, offering patients more convenient and effective treatment options. The National Institute of Health (NIH) has reported that these technologies could potentially reduce the time spent on dialysis, enhancing the quality of life for patients. As these technologies evolve, they are expected to capture a larger share of the artificial kidney market, appealing to both patients and healthcare providers. The integration of artificial intelligence and [machine learning](https://www.marketresearchfuture.com/reports/machine-learning-market-2494) in monitoring and managing kidney health also suggests a transformative shift in treatment paradigms, thereby driving the market forward. The artificial kidney market is poised for growth as these innovations become more widely adopted.

### Aging Population and Healthcare Demand

The demographic shift towards an aging population in the US is a significant driver for the artificial kidney market. As individuals age, the risk of developing kidney diseases increases, leading to a higher demand for renal replacement therapies. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, which will likely result in a surge in healthcare needs, including those related to kidney health. This demographic trend suggests that the artificial kidney market will experience increased pressure to provide innovative solutions to meet the needs of this growing patient population. Additionally, the healthcare system may need to adapt to accommodate the rising demand for artificial kidneys, potentially leading to new policies and practices that support market expansion.

### Increasing Prevalence of Kidney Diseases

The rising incidence of chronic kidney diseases (CKD) in the US is a primary driver for the artificial kidney market. According to the Centers for Disease Control and Prevention (CDC), approximately 15% of adults in the US are estimated to have CKD, which translates to millions of individuals requiring renal replacement therapies. This growing patient population necessitates innovative solutions, such as artificial kidneys, to manage their health effectively. The artificial kidney market is likely to experience substantial growth as healthcare providers seek advanced treatment options to address the increasing burden of kidney-related ailments. Furthermore, the aging population, which is more susceptible to kidney diseases, further amplifies the demand for artificial kidney solutions, indicating a robust market potential in the coming years.

## Future Outlook

The [Artificial Kidney Market](https://www.marketresearchfuture.com/reports/artificial-kidney-market-8747) is projected to grow at a 60.22% CAGR from 2025 to 2035, driven by technological advancements, increasing patient demand, and regulatory support.

**New opportunities:**

- Development of portable artificial kidney devices for home use. Partnerships with healthcare providers for integrated care solutions. Investment in R&D for next-generation bioengineered kidneys.

By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in renal care solutions.

## Segment Insights

### By Type: Wearable Artificial Kidney (Largest) vs. Implantable Artificial Kidney (Fastest-Growing)

In the US artificial kidney market, the Wearable Artificial Kidney holds a significant lead in market share, being preferred for its mobility and patient-centric design. As patients seek more flexible treatment options, this segment has capitalized on the need for devices that provide convenience without compromising efficacy. Meanwhile, the Implantable Artificial Kidney, while currently a smaller share of the market, is rapidly gaining traction due to advancements in technology that improve its feasibility and acceptance among patients.

The growth trends in this segment are driven by innovation and increasing investment in research and development. The demand for more compact and efficient kidney replacement solutions has accelerated, particularly as lifestyle-related diseases rise. As technology continues to advance, the Implantable Artificial Kidney is expected to see accelerated growth, fueled by endorsements from health professionals and improved patient outcomes that enhance its market appeal. Regulatory approvals and clinical trials also play a crucial role in shaping this dynamic landscape.

Wearable Artificial Kidney (Dominant) vs. Implantable Artificial Kidney (Emerging)

The Wearable Artificial Kidney is the dominant player in the segment, primarily due to its innovative design that allows patients greater freedom and autonomy in managing their health. This device is characterized by its portability and ease of use, which are vital considerations for patients who require continuous dialysis. Conversely, the Implantable Artificial Kidney is emerging as a promising alternative, leveraging technological advancements to address the challenges associated with traditional dialysis methods. This segment is characterized by developments aimed at creating a more permanent solution for kidney failure, which appeals to patients seeking long-term relief from the burden of frequent dialysis. Together, these segments indicate a shift toward more patient-friendly solutions in the market.

### By Dialysis: Hemodialysis (Largest) vs. Peritoneal Dialysis (Fastest-Growing)

In the US artificial kidney market, hemodialysis holds the largest market share, driven by its established presence and a well-structured healthcare framework supporting its adoption. This segment enjoys widespread acceptance among healthcare providers and patients, contributing significantly to its dominant position. On the other hand, peritoneal dialysis has been gaining traction, particularly among patients seeking more flexibility and autonomy in managing their treatment, thus capturing a notable share of the market.

The growth trends in this segment reflect a dynamic shift towards patient-centric solutions. Factors such as technological advancements, enhanced training programs for patients and providers, and an increasing awareness of the benefits of peritoneal dialysis are driving its rapid growth. Additionally, the growing prevalence of [chronic kidney diseases](https://www.marketresearchfuture.com/reports/chronic-kidney-disease-market-5744) requires effective treatment options, further propelling the demand for both hemodialysis and peritoneal dialysis in the market.

Dialysis Type: Hemodialysis (Dominant) vs. Peritoneal Dialysis (Emerging)

Hemodialysis is the dominant dialysis type in the US artificial kidney market, characterized by its extensive infrastructure and established treatment protocols. This method involves filtering blood through a machine, allowing for efficient waste removal and fluid regulation. Its widespread usage is supported by the availability of trained professionals and facilities. In contrast, peritoneal dialysis, emerging as a preferred choice among patients, allows for home-based treatment with less frequent clinical visits, enhancing patient convenience. It utilizes the body's peritoneum as a membrane for filtration, making it less invasive. The increase in the adoption of peritoneal dialysis is reflective of evolving patient preferences towards self-management and increased quality of life.

## Competitive Benchmarking

The [artificial kidney market](https://www.marketresearchfuture.com/reports/artificial-kidney-market-8747) is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for renal replacement therapies. Major players such as Fresenius Medical Care (Germany), DaVita Inc. (US), and Baxter International Inc. (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Fresenius Medical Care (Germany) focuses on innovation in dialysis technologies, while DaVita Inc. (US) emphasizes patient-centric care models. Baxter International Inc. (US) is actively pursuing partnerships to expand its product offerings, thereby shaping a competitive environment that is increasingly collaborative and innovation-driven. Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a variety of approaches to market entry and expansion, as companies leverage their unique strengths to capture market share. In October 2025, DaVita Inc. (US) announced a strategic partnership with a leading technology firm to develop AI-driven solutions for patient monitoring in dialysis. This move is significant as it aligns with the growing trend of digital health integration, potentially improving patient outcomes and operational efficiencies. By leveraging AI, DaVita aims to enhance its service delivery, thereby reinforcing its competitive edge in the market. In September 2025, Baxter International Inc. (US) launched a new line of portable dialysis machines designed for home use. This strategic initiative reflects a shift towards patient convenience and autonomy, catering to the increasing demand for home-based therapies. The introduction of these devices is likely to attract a broader patient base, positioning Baxter as a leader in innovative renal care solutions. In August 2025, Fresenius Medical Care (Germany) expanded its manufacturing capabilities in the US by investing in a new facility dedicated to producing advanced dialysis equipment. This expansion not only enhances production capacity but also signifies Fresenius's commitment to meeting the growing demand for high-quality renal therapies. Such investments are crucial for maintaining competitive advantage in a rapidly evolving market. As of November 2025, current trends in the artificial kidney market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies prioritizing R&D and strategic partnerships will likely emerge as leaders in the market.

## Report Scope

| MARKET SIZE 2024 | 115.4(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 184.9(USD Million) |
| MARKET SIZE 2035 | 20616.12(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 60.22% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Fresenius Medical Care (DE), DaVita Inc. (US), Baxter International Inc. (US), Nipro Corporation (JP), Medtronic plc (IE), Asahi Kasei Corporation (JP), KfH Kidney Center (DE), Dialysis Clinic, Inc. (US) |
| Segments Covered | Type, Dialysis |
| Key Market Opportunities | Advancements in wearable artificial kidney technologies enhance patient autonomy and treatment adherence. |
| Key Market Dynamics | Technological advancements drive innovation in artificial kidney devices, enhancing patient outcomes and market competitiveness. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US artificial kidney market in 2024?**
A: The market valuation was $115.4 Million in 2024.

**Q: What is the projected market valuation for the US artificial kidney market by 2035?**
A: The projected valuation for 2035 is $20616.12 Million.

**Q: What is the expected CAGR for the US artificial kidney market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period is 60.22%.

**Q: Which companies are considered key players in the US artificial kidney market?**
A: Key players include Fresenius Medical Care, DaVita Inc., Baxter International Inc., and others.

**Q: What are the two main types of artificial kidneys in the market?**
A: The two main types are Wearable Artificial Kidney and Implantable Artificial Kidney.

**Q: What was the market size for Wearable Artificial Kidney in 2024?**
A: The market size for Wearable Artificial Kidney was $30.0 Million in 2024.

**Q: What is the projected market size for Implantable Artificial Kidney by 2035?**
A: The projected market size for Implantable Artificial Kidney by 2035 is $8616.12 Million.

**Q: How did the Hemodialysis segment perform in 2024?**
A: The Hemodialysis segment had a valuation of $69.0 Million in 2024.

**Q: What is the expected market size for Peritoneal Dialysis by 2035?**
A: The expected market size for Peritoneal Dialysis by 2035 is $8316.12 Million.

**Q: How does the US artificial kidney market compare to other segments in terms of growth?**
A: The US artificial kidney market appears to be experiencing rapid growth, particularly with a projected CAGR of 60.22%.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-artificial-kidney-market-15673*